PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Robert Wood Johnson University Hospital Somerset, 110 Rehill Avenue, Somerville, NJ, 08876, USA.\', \'IDCare, 105 Raider Blvd, Hillsborough, NJ, 08844, USA.\', \'Robert Wood Johnson University Hospital Somerset, 110 Rehill Avenue, Somerville, NJ, 08876, USA. brunetti@pharmacy.rutgers.edu.\', \'Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ, 08854, USA. brunetti@pharmacy.rutgers.edu.\', \'Center of Excellence in Pharmaceutical Translational Research and Education, 160 Frelinghuysen Road, Piscataway, NJ, 08854, USA. brunetti@pharmacy.rutgers.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-020-76187-y
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33154452
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of tocilizumab administration on mortality in severe COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all